Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/13185
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGilbert, Richard Een
dc.contributor.authorCooper, Mark Een
dc.contributor.authorMcNally, P Gen
dc.contributor.authorO'Brien, R Cen
dc.contributor.authorTaft, Jen
dc.contributor.authorJerums, Georgeen
dc.date.accessioned2015-05-16T02:58:40Z
dc.date.available2015-05-16T02:58:40Z
dc.date.issued1994-08-09en
dc.identifier.citationDiabetic Medicine : A Journal of the British Diabetic Association; 11(7): 636-45en
dc.identifier.govdoc7955987en
dc.identifier.otherPUBMEDen
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/13185en
dc.description.abstractThirty years following the development of the first radioimmunoassay for albumin, microalbuminuria is widely acknowledged as an important predictor of overt nephropathy in patients with Type 1 diabetes and of cardiovascular mortality in Type 2 diabetes. In addition, there is accumulating evidence to suggest that diabetic patients with microalbuminuria may have more advanced retinopathy, higher blood pressure, and worse dyslipidaemia than patients with normal albumin excretion rates. Recent studies have focused on the role of intervention, principally with antihypertensive therapy and intensive glycaemic control, in reducing microalbuminuria. While successful in reducing urinary albumin excretion it remains to be established whether such therapies will be translated into a reduction in renal failure and decreased cardiovascular morbidity and mortality.en
dc.language.isoenen
dc.subject.otherAlbuminuria.epidemiology.physiopathologyen
dc.subject.otherBlood Glucose.metabolismen
dc.subject.otherBlood Pressureen
dc.subject.otherCost-Benefit Analysisen
dc.subject.otherDiabetes Mellitus.physiopathology.therapy.urineen
dc.subject.otherDiabetic Nephropathies.economics.physiopathology.prevention & controlen
dc.subject.otherHumansen
dc.subject.otherHypertension.complications.urineen
dc.subject.otherPrognosisen
dc.subject.otherUnited Statesen
dc.titleMicroalbuminuria: prognostic and therapeutic implications in diabetes mellitus.en
dc.typeJournal Articleen
dc.identifier.journaltitleDiabetic medicine : a journal of the British Diabetic Associationen
dc.identifier.affiliationEndocrinology Unit, Austin Hospital, Heidelberg, Victoria, Australiaen
dc.description.pages636-45en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/7955987en
dc.type.austinJournal Articleen
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeJournal Article-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
crisitem.author.deptEndocrinology-
Appears in Collections:Journal articles
Show simple item record

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.